acetylglucosamine has been researched along with Demyelinating Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brandt, AU; Cooper, G; Demetriou, M; Dennis, JW; Golzar, A; Lee, SU; Newton, BL; Paul, F; Pawling, J; Rahman, AMA; Scheel, M; Sy, M; Yu, Z | 1 |
| Carroll, W; Jennings, A | 1 |
| Jaeken, J | 1 |
3 other study(ies) available for acetylglucosamine and Demyelinating Diseases
| Article | Year |
|---|---|
N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation.
Topics: Acetylglucosamine; Administration, Oral; Animals; Biomarkers; Cell Differentiation; Demyelinating Diseases; Endocytosis; Female; Male; Mice; Mice, Inbred C57BL; Myelin Sheath; Neuroprotective Agents; Oligodendrocyte Precursor Cells; Receptor, Platelet-Derived Growth Factor alpha; Signal Transduction | 2020 |
GSLII positivity is not confined to oligodendrocytes in adult mammalian CNS.
Topics: Acetylglucosamine; Animals; Biomarkers; Biotinylation; Blood Cells; Cats; Demyelinating Diseases; Lectins; Macrophages; Microglia; Microscopy, Immunoelectron; Myelin Sheath; Oligodendroglia; Optic Nerve; Organ Specificity; Plant Lectins | 1999 |
[A not-previously described hereditary neurological disease with a deficiency of sialic acid, galactose and N-acetylglucosamine of plasma glycoproteins].
Topics: Acetylglucosamine; Carbohydrate Metabolism, Inborn Errors; Child, Preschool; Demyelinating Diseases; Diseases in Twins; Female; Galactose; Glucosamine; Humans; Intellectual Disability; Sialic Acids; Syndrome; Twins, Monozygotic | 1989 |